These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8628889)

  • 21. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model.
    Krueck WG; Schmiedl UP; Maravilla KR; Spence AM; Starr FL; Kenney J
    AJNR Am J Neuroradiol; 1994 Apr; 15(4):625-32. PubMed ID: 8010261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR image time-intensity relations in spleen and kidney: a comparative study of GdDTPA, albumin-(GdDTPA), and Gd2O3 colloid.
    Daly PF; Zimmerman JB; Cannillo JA; Wolf GL
    Am J Physiol Imaging; 1990; 5(3):119-24. PubMed ID: 2285522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging.
    Yu H; Su MY; Wang Z; Nalcioglu O
    Radiat Res; 2002 Aug; 158(2):152-8. PubMed ID: 12105984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent.
    Schwickert HC; Roberts TP; Mühler A; Stiskal M; Demsar F; Brasch RC
    Eur J Radiol; 1995 Jul; 20(2):144-50. PubMed ID: 7588870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability.
    Roberts HC; Saeed M; Roberts TP; Mühler A; Shames DM; Mann JS; Stiskal M; Demsar F; Brasch RC
    J Magn Reson Imaging; 1997; 7(2):331-8. PubMed ID: 9090587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies.
    Bogdanov AA; Weissleder R; Frank HW; Bogdanova AV; Nossif N; Schaffer BK; Tsai E; Papisov MI; Brady TJ
    Radiology; 1993 Jun; 187(3):701-6. PubMed ID: 8497616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute liver transplantation rejection. Early detection of endothelial leak in a rat model using magnetic resonance imaging and a macromolecular contrast medium.
    Kuwatsuru R; Liu T; Cohen F; Shames DM; Osorio RW; Mann J; Rosenau W; Mühler A; Neuder MS; Roberts JP
    Invest Radiol; 1994 Jun; 29 Suppl 2():S297-9. PubMed ID: 7928261
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique.
    Shames DM; Kuwatsuru R; Vexler V; Mühler A; Brasch RC
    Magn Reson Med; 1993 May; 29(5):616-22. PubMed ID: 8505897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative magnetic resonance imaging of capillary water permeability and regional blood volume with an intravascular MR contrast agent.
    Schwarzbauer C; Morrissey SP; Deichmann R; Hillenbrand C; Syha J; Adolf H; Nöth U; Haase A
    Magn Reson Med; 1997 May; 37(5):769-77. PubMed ID: 9126952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries.
    Daldrup HE; Shames DM; Husseini W; Wendland MF; Okuhata Y; Brasch RC
    Magn Reson Med; 1998 Oct; 40(4):537-43. PubMed ID: 9771570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of liver capillary permeability using a macromolecular contrast agent for magnetic resonance imaging.
    Clément O; Vuillemin-Bodaghi V; Cuénod CA; Siauve N; Blustajn J; Frija G
    Acad Radiol; 1996 Aug; 3 Suppl 2():S342-3. PubMed ID: 8796598
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI.
    Su MY; Wang Z; Roth GM; Lao X; Samoszuk MK; Nalcioglu O
    Magn Reson Med; 1996 Dec; 36(6):868-77. PubMed ID: 8946352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbeam Radiation Therapy Opens a Several Days' Vessel Permeability Window for Small Molecules in Brain Tumor Vessels.
    Potez M; Rome C; Lemasson B; Heemeryck P; Laissue JA; Stupar V; Mathieu H; Collomb N; Barbier EL; Djonov V; Bouchet A
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1506-1516. PubMed ID: 38373658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast-enhanced MRI.
    Brasch RC; Berthezène Y; Vexler V; Rosenau W; Clément O; Mühler A; Kuwatsuru R; Shames DM
    Pediatr Radiol; 1993; 23(7):495-500. PubMed ID: 8309747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging contrast agent.
    Berthezene Y; Vexler V; Jerome H; Sievers R; Moseley ME; Brasch RC
    Radiology; 1991 Dec; 181(3):773-7. PubMed ID: 1947095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.
    Wilkins DE; Raaphorst GP; Saunders JK; Sutherland GR; Smith IC
    Magn Reson Imaging; 1995; 13(1):89-96. PubMed ID: 7898284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats.
    Fournier LS; Novikov V; Lucidi V; Fu Y; Miller T; Floyd E; Shames DM; Brasch RC
    Radiology; 2007 Apr; 243(1):105-11. PubMed ID: 17329684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agents.
    Aref M; Brechbiel M; Wiener EC
    Invest Radiol; 2002 Apr; 37(4):178-92. PubMed ID: 11923640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.